Similarly, -synuclein oligomers intervene with organellar functions and interact with metal ions to cause oxidative stress 14
[] Studies using magnetic resonance (MR) spectroscopy have shown that the PFC of patients with schizophrenia has changed glutamate and amounts of glutathione
A GLP-1 lawsuit allows victims to seek damages for: Past and future medical care (neuro-ophthalmology visits, low-vision therapy)
It highlights that GLP-1 is no longer viewed just as a "gut hormone" but as a systemic regulator of immune and inflammatory responses
Semaglutide slows gastric emptying and digestive movement as part of how it controls appetite
World Obesity underscores the need for: More research within LMIC health systems, where capacity for obesity care is limited Longitudinal studies on medium- and long-term outcomes Better understanding of lived experience with GLP-1 therapy - including benefits, challenges, and impacts on stigma and quality of life This work aligns closely with World Obesitys MAPPS II study, which is mapping disparities in global obesity care and identifying system-level levers to strengthen access
